[PDF][PDF] PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy

U Haberkorn, LG Strauss… - Journal of Nuclear …, 1991 - Soc Nuclear Med
Forty-four patients with recurrent colorectal carcinoma were examined prior to a combination
of conventional photon radiotherapy (40 Gy) and neutron therapy (10 Gy). Twenty-one of …

Recurrence of colorectal tumors: PET evaluation.

LG Strauss, JH Clorius, P Schlag, B Lehner, B Kimmig… - Radiology, 1989 - pubs.rsna.org
Positron emission tomography (PET) was used in the follow-up of patients with colorectal
malignancies to differentiate between recurrent colorectal tumor and scar. Patients were …

Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.

Y Ichiya, Y Kuwabara, M Otsuka, T Tahara… - Journal of nuclear …, 1991 - europepmc.org
In order to evaluate the usefulness of 18F-FDG PET in the assessment of therapeutic effects,
FDG-PET studies were performed both before and after therapy in 26 patients with …

[PDF][PDF] In Vitro Assessment of 2-fluoro-2-deoxy-D glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to …

K Higashi, AC Clavo, RL Wahl - Journal of Nuclear Medicine, 1993 - Soc Nuclear Med
(13). These changes have been attributed to †œinflamma tion― induced by
irradiation(13). Thus, it appeared impor tant to clarify the relationship of FDG, methionine …

[PDF][PDF] Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with …

M Findlay, H Young, D Cunningham, A Iveson… - Journal of Clinical …, 1996 - Citeseer
Purpose: To investigate and measure the metabolism of colorectal cancer liver metastases
using 18F-fluorodeoxyglucose positron emission tomography (FDG PET), before and during …

Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.

MA Goldberg, MJ Lee, AJ Fischman, PR Mueller… - Radiographics, 1993 - pubs.rsna.org
Fluorine-18-fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) was used to
image 38 patients with known or suspected malignant processes involving the abdomen or …

[PDF][PDF] Early changes in fluorine-18-FDG uptake during radiotherapy

H Hautzel, HW Müller-Gärtner - Journal of Nuclear Medicine, 1997 - Soc Nuclear Med
DISCUSSION Investigations of the impact of irradiation on the glucose metabolism show a
decrease of FDG uptake in radiosensitive tumors (5, 8). However, no investigations focused …

Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer

G Beets, F Penninckx, C Schiepers, L Filez… - Journal of British …, 1994 - academic.oup.com
To assess the clinical value of whole-body positron emission tomography (PET) with [18F]
fluorodeoxyglucose (FDG) in recurrent colorectal cancer, 35 patients were studied: 15 had …

Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET

T Fukunaga, S Okazumi, Y Koide… - The Journal of …, 1998 - search.proquest.com
18-Fluorodeoxyglucose PET Page 1 Evaluation of Esophageal Cancers Using Fluorine18-Fluorodeoxyglucose
PET Toru Fukunaga, Shinichi Okazumi. Yoshio Koide, Kaichi lsono and Keiko lmazeki …

Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice

J Ruhlmann, A Schomburg, H Bender… - Diseases of the colon …, 1997 - journals.lww.com
PURPOSE: To evaluate the routine clinical value of attenuation-corrected whole-body
fluorodeoxyglucose positron emission tomography in colorectal cancer, a total of 59 patients …